A phosphorylation switch controls androgen biosynthesis in prostate cancer
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci166499 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Yun Qiu. Beteiligte Einrichtung: Departments of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA.
Abstract (Originalsprache)
Androgen biosynthesis enzyme 3β-hydroxysteroid dehydrogenase type 1 (3βHSD1) encoded by HSD3B1 has emerged as a potential driver for therapeutic resistance in prostate cancer. Patients with homozygous HSD3B1(1245C) inheritance are intrinsically more resistant to currently available androgen/androgen receptor-targeting (AR-targeting) drugs. In this issue of the JCI, Li et al. present data on the regulation of 3βHSD1 phosphorylation and activity by tyrosine kinase BMX. Inhibition of BMX activity by genetic or pharmacologic approaches blocked androgen biosynthesis in prostate cancer cells and inhibited tumor growth in preclinical xenograft models. The findings provide insights into mechanisms underlying castration resistance in prostate cancer and reveal a potential strategy to circumvent therapeutic resistance in patients with homozygous HSD3B1(1245C) inheritance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Pharmacology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- Veterans Affairs Maryland Health Care System (VAMHCS), Baltimore, Maryland, USA.
Förderung
- BLRD VA
Zitieren
APA
Qiu, Y. (2023). A phosphorylation switch controls androgen biosynthesis in prostate cancer. Journal of Clinical Investigation. https://doi.org/10.1172/jci166499
Vancouver
Qiu Y. A phosphorylation switch controls androgen biosynthesis in prostate cancer. Journal of Clinical Investigation. 2023. doi:10.1172/jci166499
BibTeX
@article{Qiu2023,
author = {Qiu, Yun},
title = {A phosphorylation switch controls androgen biosynthesis in prostate cancer},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci166499}
}
EUVIMED